# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-067915
Filing Date
2024-06-04
Accepted
2024-06-03 17:45:29
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-06-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm2416228-2_ars.pdf | ARS | 688617
| Complete submission text file | 0001104659-24-067915.txt |  | 949900

Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: ARS | Act: 34 | File No.: 001-36288 | Film No.: 241015239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)